Learn about Severe Developmental & Epileptic Encephalopathy (DEE). One of the five known phenotypes,
Severe DEE is where we find those most profoundly affected by SCN8A-related disorders.
Home ➔ Diagnosis & Treatment of SCN8A ➔ SCN8A Phenotypes ➔ Severe DEE
Severe DEE is a serious disorder that begins in infancy. It causes frequent, difficult-to-control seizures and significant delays in a child’s development. As children get older, they often experience problems with movement, speaking, eating, and other bodily functions. Sadly, Severe DEE can shorten a child’s lifespan and puts them at high risk for SUDEP.
Seizure Onset | 0 - 6 Months | |
Developmental Delay Onset | 0 - 6 Months | |
Seizure Types | Focal, Generalized, Infantile Spasms | |
Clinical Features | Limited Mobility, Cognitive Function, and Functional Vision; Non-Verbal; Cannot Eat by Mouth | |
Seizure Freedom | Rarely/Never | |
Prognosis | Limited Change to Deterioration |
Seizure Onset
0 – 6 Months
Developmental Delay Onset
0 – 6 Months
Seizure Types
Focal, Generalized, Infantile Spasms
Clinical Features
Limited Mobility, Cognitive Function, and Functional Vision; Non-Verbal; Cannot Eat by Mouth
Seizure Freedom
Rarely/Never
Prognosis
Limited Change to Deterioration
Optimal first-line medications | Oxcarbazepine, Carbamazepine |
Medications to be cautious of | Levitracitacitam |
Important considerations | Gain-of-function (GOF) variants are more common, so sodium channel blockers are preferred. Levetiracetam may worsen seizures and is generally avoided in patients with GOF variants. Ketogenic diet can be helpful |
Rescue Medication | IV phenytoin or phenytoin are recommended for status epilepticus |
⯆ Keep Exploring ⯆
Home ➔ Diagnosis & Treatment of SCN8A ➔ SCN8A Phenotypes ➔ Severe DEE
IMPORTANT: While this consensus data provides new and valuable insights about best practices in the diagnosis and treatment of SCN8A, this is not medical advice. It can inform clinicians and caregivers alike in developing optimal treatment plans for each individual.